DUBLIN–(BUSINESS WIRE)–The “AI in Biotechnology: Global Markets” report has been added to ResearchAndMarkets.com’s offering. The global market for AI in biotechnology was valued at $3.8 billion in 2024. The market is estimated to grow from $4.6 billion in 2025 to $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 20% from 2025 … [Read more…]

WATERLOO, Iowa–(BUSINESS WIRE)–HOMELINK®, a leading provider of integrated specialty services for the workers’ compensation and group health industries, is pleased to welcome Allan Schroeder, J.D., as vice president of managed care. Schroeder is a seasoned executive with a deep background in clinical review services and healthcare operations. “Allan brings a great combination of strategic insight … [Read more…]

RC Capital, Mutual Capital Partners and Western Alliance Bank reinforce long-term confidence in Catalyst’s vision and leadership; Dr. Theodore Blaine joins Catalyst board of directors NAPLES, Fla.–(BUSINESS WIRE)–Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced the close of $15 million in equity and debt financing, … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–#biosciences—Mispro today announced the opening of its newest contract vivarium facility in Kendall Square, Cambridge, scheduled to open in December 2025. Located in the heart of the world’s leading life sciences hub, the new facility will be Mispro’s ninth in the Greater Boston area and third in Kendall Square, strengthening its position as … [Read more…]

The PROCLIPI study, one of the largest studies to date in cutaneous T-cell lymphoma (CTCL), is a prospective, observational, multicentre international registry spanning 19 countries and includes over 2,000 patients, collects data to develop prognostic indices for CTCL1 An analysis of 371 patients observed meaningful overall survival (OS) benefit for patients with advanced mycosis fungoides … [Read more…]

LEHI, Utah–(BUSINESS WIRE)–$owlt #babymonitor–Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced the pricing of an underwritten public offering of 4,196,000 shares of the Company’s Class A common stock (the “Offering”). The shares of Class A common stock are being sold at a public offering price of $7.15 … [Read more…]

Takeda to Receive Rights to Two Next-Generation Late-Stage Investigational Medicines, Worldwide Outside of Greater China, and an Exclusive Option to License Global Rights to an Early-Stage Program Takeda to Lead IBI363 Global Co-Development and U.S. Co-Commercialization and Will Have Exclusive Commercialization Rights Outside the U.S. and Greater China; IBI363 is a Late-Stage Bispecific Antibody Fusion … [Read more…]

WASHINGTON–(BUSINESS WIRE)–A network of over 30 rural and urban nonprofit safety net providers appealed to congressional leaders to protect the 340B Drug Pricing Program, highlighting how the program enables the high-quality care they provide to medically underserved Americans. The 340B Rural Advocacy Network released the letter prior to a U.S. Senate Health Education Labor and … [Read more…]

FREMONT, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that it will release its third quarter 2025 financial results on Tuesday, November 4, 2025. In conjunction with the release, Personalis will host a conference call and webcast that day at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern … [Read more…]

A Global Turning Point for Critical Care Medicine TOULOUSE, France & FULLERTON, Calif.–(BUSINESS WIRE)–ABIONYX Pharma, (FR0012616852 – ABNX – PEA PME eligible), a new generation biotech company dedicated to the world’s only recombinant apoA-I, today announced the publication of a ground breaking study in Scientific Reports in Nature Portfolio titled “Plasma apolipoprotein A-I is a … [Read more…]